These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 16968566

  • 1. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 2. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 3. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 4. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N, Kamijo A, Kuwahara H, Uchiyama M, Shimizu T, Chiba S, Inoue Y.
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [Abstract] [Full Text] [Related]

  • 5. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 6. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T.
    Biol Psychiatry; 2006 Jun 01; 59(11):1052-60. PubMed ID: 16581036
    [Abstract] [Full Text] [Related]

  • 7. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
    Rosenberg R, Caron J, Roth T, Amato D.
    Sleep Med; 2005 Jan 01; 6(1):15-22. PubMed ID: 15680290
    [Abstract] [Full Text] [Related]

  • 8. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK, Salkeld L, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2010 Jan 01; 11(1):23-30. PubMed ID: 19945340
    [Abstract] [Full Text] [Related]

  • 9. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
    Boyle J, Trick L, Johnsen S, Roach J, Rubens R.
    Hum Psychopharmacol; 2008 Jul 01; 23(5):385-97. PubMed ID: 18350566
    [Abstract] [Full Text] [Related]

  • 10. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 01; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 01; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 14. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
    Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM.
    J Clin Psychiatry; 2011 Jul 15; 72(7):892-7. PubMed ID: 21367352
    [Abstract] [Full Text] [Related]

  • 15. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
    Scharf M, Erman M, Rosenberg R, Seiden D, McCall WV, Amato D, Wessel TC.
    Sleep; 2005 Jun 15; 28(6):720-7. PubMed ID: 16477959
    [Abstract] [Full Text] [Related]

  • 16. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
    Rosenberg R, Roach JM, Scharf M, Amato DA.
    Sleep Med; 2007 Aug 15; 8(5):464-70. PubMed ID: 17512799
    [Abstract] [Full Text] [Related]

  • 17. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
    Ancoli-Israel S, Krystal AD, McCall WV, Schaefer K, Wilson A, Claus R, Rubens R, Roth T.
    Sleep; 2010 Feb 15; 33(2):225-34. PubMed ID: 20175406
    [Abstract] [Full Text] [Related]

  • 18. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T.
    Sleep; 2003 Nov 01; 26(7):793-9. PubMed ID: 14655910
    [Abstract] [Full Text] [Related]

  • 19. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H, Petrillo L, Viguera A, Koukopoulos A, Silver-Heilman K, Farrell A, Yu G, Silver M, Cohen LS.
    Am J Obstet Gynecol; 2010 Feb 01; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [Abstract] [Full Text] [Related]

  • 20. A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.
    Krystal AD, Huang H, Zummo J, Grinnell T, Marshall RD.
    Sleep Med; 2012 Jun 01; 13(6):691-6. PubMed ID: 22465450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.